The G Protein-Coupled Receptor Agtrl1b Regulates Early Development of Myocardial Progenitors  by Scott, Ian C. et al.
Developmental Cell
ArticleTheGProtein-CoupledReceptorAgtrl1bRegulates
Early Development of Myocardial Progenitors
Ian C. Scott,1,4,* Bernard Masri,3 Leonard A. D’Amico,1 Suk-Won Jin,1,5 Benno Jungblut,1 Ann M. Wehman,2
Herwig Baier,2 Yves Audigier,3 and Didier Y.R. Stainier1,*
1Department of Biochemistry and Biophysics, Programs in Developmental Biology, Genetics and Human Genetics,
and Cardiovascular Research Institute
2Department of Physiology
University of California, San Francisco, 1550 4th Street, San Francisco, CA 94158, USA
3 Institut Louis Bugnard, Unite INSERM U-589, 31432-Toulouse, France
4Present address: The Hospital for Sick Children, Program in Developmental and Stem Cell Biology, 101 College Street,
TMDT East Tower 11-307, Toronto, Ontario M5G 1L8, Canada.
5Present address: Department of Cell and Molecular Physiology, University of North Carolina, Chapel Hill, NC 27599, USA.
*Correspondence: ian.scott@sickkids.ca (I.C.S.), didier_stainier@biochem.ucsf.edu (D.Y.R.S.)
DOI 10.1016/j.devcel.2007.01.012SUMMARY
While many factors that modulate the morpho-
genesis and patterning of the embryonic heart
have been identified, relatively little is known
about the molecular events that regulate the
differentiation of progenitor cells fated to form
the myocardium. Here, we show that zebrafish
grinch (grn) mutants form a reduced number
of myocardial progenitor cells, which results in
a profound deficit in cardiomyocyte numbers
in the most severe cases. We show that grn en-
codes the G protein-coupled receptor (GPCR)
Agtrl1b, a known regulator of adult cardiovas-
cular physiology. Ectopic expression of Apelin,
an Agtrl1b ligand, results in the complete ab-
sence of cardiomyocytes. Data from transplan-
tation and transgenic approaches indicate that
Agtrl1 signaling plays a cell-autonomous role
in myocardial specification, with activity being
required coincident with the onset of gastrula-
tion movements. These results support a model
in which agtrl1b regulates the migration of cells
fated to form myocardial progenitors.
INTRODUCTION
Organogenesis begins with the development of progenitor
cells that later differentiate to form the specialized tissues
required for organ function. In vertebrates, myocardial
progenitors can first be distinguished by nkx2.5 expres-
sion in two bilateral stripes of cells in the anterior lateral
plate mesoderm (ALPM) (Harvey, 1996). Prior to the onset
of nkx2.5 expression, fate-mapping studies in several
vertebrates have shown that myocardial progenitor cells
ingress early during gastrulation (Stainier et al., 1993;
Parameswaran and Tam, 1995; Schoenwolf and Garcia-
Martinez, 1995; Keegan et al., 2004). Multiple signaling
pathways, acting in both stimulatory and inhibitory fash-Developions, act to restrict cardiomyogenesis to a defined domain
in the ALPM. These signals include TGF-bs, Fgfs, Shh, and
Wnts/Wnt inhibitors (Schultheiss et al., 1997; Reifers et al.,
2000; Schneider and Mercola, 2001; Zhang et al., 2001).
Relatively little is known regarding mechanisms that
specifically affect myocardial progenitor specification
and migration to the ALPM prior to the onset of nkx2.5 ex-
pression. Explant studies in chick have suggested that
signals are required for cardiomyogenesis prior to gas-
trulation (Antin et al., 1994). In gastrula-stage zebrafish
embryos, retinoic acid (RA) signaling acts to restrict the
number of myocardial progenitor cells formed (Keegan
et al., 2005). Members of the Mesp transcription factor
gene family are broadly expressed in the murine primitive
streak, and they are required for the ingression of cardio-
vascular progenitors during gastrulation (Saga et al.,
1999). Heart development is severely perturbed in
Mesp1/2 double mutants (Kitajima et al., 2000), as well
as in ascidian embryos depleted of mesp function by in-
jection of antisense oligonucleotides (Satou et al., 2004).
In this study, we used a forward genetic approach in
zebrafish to identify possible novel regulators of early
cardiac development. We describe a mutation, grinch,
that greatly inhibits the development of the myocardium.
Activity of the gene affected by this mutation, agtrl1b, is
shown to be required early in myocardial progenitors, co-
incident with the onset of gastrulation. To our knowledge,
these results therefore identify a novel signaling pathway
required for myocardial development.
RESULTS
grinch Mutants Have a Specific and Early Defect
in Cardiomyogenesis
In order to identify additional regulators of cardiac devel-
opment, we carried out a forward genetic screen and
assayed heart morphology at 52 and 96 hours postfertili-
zation (hpf) (Beis et al., 2005). A single allele of a novel
recessive mutation, grinchs608 (grn), was identified and
caused amarked reduction in the size of the heart (Figures
1A and 1B). While the expressivity of the grn phenotype ismental Cell 12, 403–413, March 2007 ª2007 Elsevier Inc. 403
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Role of agtrl1b in Myocardial ProgenitorsFigure 1. The grns608 Mutation Affects Cardiomyocyte Specification
(A and B) Lateral views of 48 hpf embryos from grns608 heterozygote incrosses. In severe cases, mutant embryos ([A], top; [B]) lack a distinguishable
heart (arrow); however, this defect is variable within the same clutch.
(C–F) cmlc2 ISH at 24 hpf on (C) wild-type (WT) and (D–F) grns608 mutant embryos.
(G and H) tbx5 ISH on 48 hpf (G) WT and (H) grns608 mutant embryos. Arrowheads denote pectoral fin buds.
(I–K) nkx2.5 in 14 hpf (I) WT and (J and K) grns608 mutant embryos; dorsal views, anterior is oriented toward the left.variable, in the most extreme cases no or only a very small
number of cardiac myosin light chain 2 (cmlc2)-positive
cardiomyocytes are present (Figures 1C–1F). The grn phe-
notype is partially affected by genetic background, as dif-
ferent pairs of mutant carriers reproducibly yield embryos
with differing severities of phenotype (data not shown). A
striking aspect of the grn phenotype is its specificity to
the heart. Severely affected grn mutants are viable until
6–7 days postfertilization (dpf), with the only notably aber-404 Developmental Cell 12, 403–413, March 2007 ª2007 Elsevrant features being pericardial edema and the absence of
a heart. Development of the endoderm, vasculature, pos-
terior LPM, and somitic mesoderm appears unaffected
(Figures S1A–S1E; see the Supplemental Data available
with this article online). The pectoral fins, an ALPM deriv-
ative, form in grn mutants as in wild-type siblings (as
shown by tbx5 expression, Figures 1G and 1H). Therefore,
the effects of the grn mutation on the LPM appear to be
confined to the myocardial lineage.ier Inc.
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Role of agtrl1b in Myocardial ProgenitorsTo determine the nature of the grn myocardial defect,
various stages of heart development were examined. At
12.5 hpf, nkx2.5 expression is greatly reduced in a subset
of grnmutants (Figures 1I–1K), indicating a defect in early
myocardial specification. In contrast, later aspects of dif-
ferentiation appear normal in the few cardiomyocytes
formed in severe grnmutants. Expression of the chamber-
specific genes amhc and vmhc (Yelon et al., 1999) is
established (Figures S1F and S1G), and cells are contrac-
tile. Cardia bifida is not observed in grnmutants, indicating
that the nkx2.5+ cells formed can migrate to the midline.
Finally, mild grn mutants with a wild-type-sized heart sur-
vive to adulthood and are fertile. Taken together, these
data suggest that grn activity is required prior to the estab-
lishment of nkx2.5-positive myocardial progenitors in the
ALPM, but appears dispensable for later aspects of
embryonic heart development and function. The variable
expressivity of the grn phenotype is not due to maternal
contribution, as intercrosses of homozygous mutant grn
carriers yield a phenotype indistinguishable from the
zygotic one (data not shown). The observed variability
could be due to the fact that grns608 is not a null muta-
tion or that grn functions in parallel with other genetic
pathways.
The grinch Phenotype Is Due to a Mutation in agtrl1b
To gain further insight into the nature of grn activity, we
sought to identify the gene affected by the grns608 muta-
tion. Using single-sequence length polymorphisms
(SSLP) and restriction fragment length polymorphism
(RFLP) markers, the grn locus was shown to reside on link-
age group 10, with tight linkage to the BAC zC102K8. Se-
quence analysis of zC102K8 revealed the presence of an
ORF with homology to the GPCR gene agtrl1 (a.k.a. apj,
X-msr, and angio1 [Audigier, 2006]) (Figure S2A). Se-
quencing of the agtrl1b cDNA showed that the s608 allele
contains a G to T base pair change at position 269, creat-
ing a tryptophan to leucine amino acid change in the sec-
ond transmembrane domain (Figures S2B and S2C). This
tryptophan residue is fully conserved in all Agtrl1 orthologs
characterized to date, as well as in the related Angiotensin
and CXC chemokine receptor families (data not shown).
Therefore, it seems likely that the loss of this bulky hydro-
phobic amino acid in a transmembrane domain should
have a significant impact on Agtrl1b function.
To test whether a mutation in agtrl1b causes the grn
phenotype, biochemical, loss-of-function, and rescue ap-
proaches were undertaken. Mammalian Agtrl1 signals via
binding of Apelin (Apln) peptide ligands (Tatemoto et al.,
1998; Masri et al., 2002, 2004). Cells stably overexpress-
ing zebrafish agtrl1b are responsive to both 13 and 36
amino acid human Apln peptides, resulting in adenylylcy-
clase inhibition and phosphorylation of ERK and p70S6 ki-
nase (Figures 2A–2C). These data validate the assignment
of Agtrl1b as a zebrafish ortholog of the Apln receptor. In
contrast to the wild-type gene, the grns608 allele of agtrl1b
is completely unresponsive to stimulation by Apln in these
assays. Therefore, by biochemical criteria, the grns608 al-
lele of agtrl1b appears to encode a functionally inactiveDevelopreceptor. To further appraise the requirement for agtrl1b
in heart development, morpholino (MO) antisense oligonu-
cleotides were used. Injection of 2.0 ng of a MO targeting
the 50UTR of agtrl1b resulted in a strong reduction of car-
diomyocyte differentiation, as assayed by cmlc2 expres-
sion at 24 hpf (Figures 2D–2F), as well as decreased
nkx2.5 expression at the 10-somite stage (Figures 2G
and 2H). In contrast, a 5 base pair mismatch control MO
had no effect on heart development. Injection of higher
concentrations of agtrl1b MO yielded a fully penetrant
loss of heart formation. However, these morphants also
exhibited stunted growth and brain necrosis, possibly
due to toxic side effects of the MO (Figure 2I). In order to
further assess whether grn encodes agtrl1b, rescue ex-
periments were performed. Injection of agtrl1b mRNA
into embryos derived from intercrosses of homozygous
mutant grns608 carriers resulted in a substantial rescue of
heart size and function (Figures 2J and 2K; Table S1). In
many cases, circulation was restored in the injected em-
bryos, which could, in turn, be raised to adulthood. Taken
together, the preponderance of tight linkage, biochemical,
MO loss-of-function, and RNA rescue data indicate that
agtrl1b is indeed the gene affected by the grns608 muta-
tion. Injection of RNA encoding Agtrl1bs608 at high con-
centrations had no effect on cardiac development in
wild-type embryos (data not shown). Coupled with the ab-
sence of a heterozygous grn phenotype, these results
strongly suggest that Agtrl1bs608 does not have dominant-
negative effects.
agtrl1b Is Expressed Broadly in Mesendodermal
Progenitors
To help define when agtrl1b acts to regulate myocardial
differentiation, gene expression was examined by in situ
hybridization. agtrl1b transcripts are detectable prior to
the onset of gastrulation at sphere stage (4 hpf) in scat-
tered cells in the animal pole of the embryo (Figure 3A).
By 50% epiboly (5.3 hpf), agtrl1b expression is restricted
to the ventral and lateral margins, the latter of which in-
clude the myocardial progenitors (Stainier et al., 1993;
Keegan et al., 2004), but is excluded from the dorsal orga-
nizer region (Figure 3B). As gastrulation proceeds from 5
hpf onward, agtrl1b expression expands toward the ani-
mal pole, in concert with the movement of cells from the
margin toward the axis of the embryo (Figure 3C). By
bud stage (10 hpf), agtrl1b transcripts are localized poste-
riorly in the presomitic mesoderm and in adaxial cells
adjacent to the midline, coincident with the first clearly
detectable expression of apln in the embryonic midline
proper (Figures 3D–3F). At somitogenesis stages, agtrl1b
continues to be expressed in somitic mesoderm, with an
additional domain of expression in the ALPM, medial to
the nkx2.5+ myocardial progenitors (Figures 3G–3J, com-
pare arrows and arrowheads). At later stages, agtrl1b ex-
pression is prominent in the developing vasculature, in-
cluding both major trunk vessels—the dorsal aorta and
the posterior cardinal vein—as well as the branching inter-
somitic vessels (Figures 3K and 3L). This later vascular
expression of agtrl1b suggests that the medial ALPMmental Cell 12, 403–413, March 2007 ª2007 Elsevier Inc. 405
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Role of agtrl1b in Myocardial ProgenitorsFigure 2. grns608 Is a Mutation in agtrl1b
(A–C) Analysis of Agtrl1b signaling. (A) Inhibition of adenylylcyclase activity, and (B and C) phosphorylation of ERK and p70S6 kinase by WT, but not
mutant, agtrl1b upon Apln addition.406 Developmental Cell 12, 403–413, March 2007 ª2007 Elsevier Inc.
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Role of agtrl1b in Myocardial Progenitorsexpression at 11 hpf is likely in the nascent endocardial
cells. As the endocardium appears to be dispensable for
myocardial induction in zebrafish (Stainier et al., 1995), ex-
pression of agtrl1b in the margin at blastula and gastrula
stages, and exclusion of detectable agtrl1b transcripts
from the myocardium later, suggests an early role for
Agtrl1b function in the development of themyocardial pro-
genitors. Further, as expression of agtrl1b is highly similar
to what has been described for the single Xenopus agtrl1
gene (Devic et al., 1996), this early function for agtrl1bmay
be evolutionarily conserved.
The expression pattern observed for agtrl1b at early
stages of embryogenesis is similar to that described for
agtrl1a, a second agtrl1 homolog in zebrafish (Tucker
et al., 2006). To investigate possible redundant functions
of these two genes, an MO targeting agtrl1a was injected
into grn mutants. In crosses in which the grn phenotype
was weak and heart development proceeded normally,
further depletion of agtrl1a resulted in a small heart pheno-
type (Figures 2L–2N). These data suggest that agtrl1a/b
act redundantly. However, additional genetic pathways
appear to be required to regulate cardiogenesis (see
Discussion).
Early Ectopic Activation of Agtrl1b Signaling Blocks
Myocardial Progenitor Formation
To gain additional insights into Agtrl1b activity, gain-
of-function experiments were conducted. Remarkably,
injection of 25–100 pg zebrafish apln mRNA at the 1-cell
stage resulted in the complete absence of myocardial dif-
ferentiation. Expression of cmlc2 at 24 hpf was severely
inhibited by apln injection (Figures 4A and 4B). Similarly,
early expression of nkx2.5 was sharply reduced at 14 hpf
(Figures 4C and 4D). These phenotypes were highly con-
sistent, as opposed to the variable expressivity observed
in the cases of agtrl1b knockdowns via mutation or MO
injection. Identical results were obtained from injection
of murine apln mRNA (data not shown). In contrast to
the severe effects on myocardial differentiation, addition
of apln had no discernable effect on the development of
other mesodermal populations, including the blood, skel-
etal muscle, and vasculature (Figures S3A–S3C). Despite
the broad expression of agtrl1b in the margin, the effects
of Agtrl1b signaling thus appear to be specific to the
myocardial progenitors.
To determine the fate of myocardial progenitors in em-
bryos injected with apln, we examined the morphology
of the ALPM, where nkx2.5 expression first arises. gata5
and hand2 expression analyses reveal the bilateral
ALPM epithelial sheets in wild-type embryos at 12 hpf
(Figure 4E, similar data not shown for hand2). In contrast,Developembryos injected with apln RNA exhibited severe defects
in ALPMmorphogenesis (Figure 4F). Discontinuities in the
ALPM were often evident (>80% of embryos, n = 200). In
addition, streams of cells projecting laterally away from
the ALPM were observed. A consistent decrease in the
size of the ALPM was also characteristic of apln-injected
embryos (Figure 4G). The effect of apln RNA on ALPM
morphogenesis appeared to be specific, as coinjection
of an apln 50UTRMOabolished this phenotype (Figure 4H).
These results suggest that cells fated to form the myocar-
dium do not reach their correct position upon overexpres-
sion of apln. The defects in the integrity of the ALPM may
therefore be secondary to an absence of these cells. In
contrast to these results, the ALPM appears unaffected
in grinch mutants (data not shown), suggesting that the
phenotype observed after overexpression of apln is not
simply due to a ligand-dependent downregulation of
Agtrl1b.
To define the developmental period over which Agtrl1b
signaling is required for myocardial differentiation, we
used an inducible apln transgene driven by a zebrafish
hsp70 promoter fragment (Halloran et al., 2000). Embryos
subjected to a 30 min heat shock at late blastula stages
(3 hpf) developed an acardiac phenotype at 24–48 hpf
(Figure 4I). Morphological defects were also apparent,
with embryos displaying a shortened axis and clumping
of cells in the trunk region. Heat shock was performed at
various time points to examine the window over which
ectopic signaling by Apln blocked heart development.
A sharp transition was observable at 5 hpf: prior to this
time, heat shock of transgenic embryos resulted in no
cardiomyocytes being formed. In contrast, heat shock at
6 hpf or later had subtle or no effects onmyocardial forma-
tion (Figures 4J–4L). Genotyping of embryos confirmed
that all transgenic carriers (and only those) were affected
if shocked prior to 5 hpf. These experiments therefore de-
fine a narrow period of time (between 3 and 5 hpf) during
which Apln expression throughout the embryo blocked
cardiogenesis. Interestingly, gastrulation is initiated in ze-
brafish at 5 hpf. Therefore, the time period during which
cardiogenesis is sensitive to hsp70:apln activation imme-
diately precedes the onset of gastrulation.
agtrl1b Activity Is Required in Myocardial
Progenitors
To determine whether Agtrl1b signaling is required in
myocardial progenitors or other cells, we performed
transplantation experiments. Donor embryos carrying a
cmlc2:EGFP transgene were used, allowing for the iden-
tification of donor cells that had taken a myocardial fate
after transplantation. Transplantation of 3–4 hpf (late(D–H) MO phenocopy of the grn phenotype. cmlc2 ISH at 24 hpf on embryos injected with (D) mismatch control MO or a (E and F) 50UTR agtrl1bMO.
nkx2.5 ISH on 10-somite embryos injected with (G) mismatch control and (H) agtrl1b MO.
(I) Abnormal morphogenesis and brain necrosis in a 24 hpf embryo injected with an increased concentration of agtrl1b MO.
(J and K) Rescue of the grn phenotype by injection of agtrl1bRNA. 48 hpf mutant embryos (J) uninjected or (K) injected with 100 pg agtrl1bmRNA. The
arrow denotes pericardial edema and lack of heart in uninjected controls.
(L–N) Redundancy of agtrl1a and agtrl1b. Relatively unaffected heart development in (L) mild grnmutants, as shown by cmlc2 ISH (arrows) at 48 hpf, is
worsened considerably by (M and N) coinjection of agtrl1a MO.mental Cell 12, 403–413, March 2007 ª2007 Elsevier Inc. 407
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Role of agtrl1b in Myocardial ProgenitorsFigure 3. Expression of agtrl1b Is Consistent with an Early Role in Myocardial Progenitor Development
(A–D) Expression of agtrl1b at (A) 4 hpf (sphere), (B) 5.3 hpf (50% epiboly), (C) 6 hpf (shield), and (D) 10 hpf (bud) stages. agtrl1b is expressed broadly in
the mesendoderm.
(E and F) Expression of apln in the embryonic midline. apln ISH at (E) 10 hpf and (F) 12.5 hpf (7-somite) stages. Arrowheads denote apln expression in
the midline.
(G–J) ALPM expression of agtrl1b in the endocardial progenitors; anterior is oriented toward the left. Expression of agtrl1b (arrows) at (G) 11 and (I)
12.5 hpf is medial to (H and J) nkx2.5 expression (arrowheads) at equivalent stages.
(K and L) Vascular expression of agtrl1b. At (K) 22 and (L) 48 hpf agtrl1b transcripts localize to endothelial cells.408 Developmental Cell 12, 403–413, March 2007 ª2007 Elsevier Inc.
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Role of agtrl1b in Myocardial ProgenitorsFigure 4. Early Cell-Autonomous Role of Agtrl1b Signaling in Cardiomyogenesis
(A and B) 24 hpf embryos injected with 100 pg apln mRNA. Fewer cmlc2-positive cardiomyocytes in (B) injected versus (A) uninjected embryos.
(C and D) Injection of apln affects myocardial progenitor specification. nkx2.5 ISH on 14 hpf embryos (C) uninjected and (D) injected with 100 pg apln
mRNA.
(E–H) gata5 ISH on 12 hpf embryos (E) uninjected, (F and G) injected with 100 pg aplnRNA, or (H) injected with 100 pg aplnRNA and 9.2 ng apln 50UTR
MO; anterior is oriented toward the left.
(I–L) The hsp:apln transgene can recapitulate aplnRNA effects on cardiacmyogenesis. (I) Early heat shock at 3 hpf causes axial truncations. (J–L) Heat
shock at 3 or 5 hpf, but not at 6 hpf, blocks cardiac myogenesis, as shown by cmlc2 expression at 48 hpf.
(M–P) Transplantation of cmlc2:EGFP cells to WT host embryos. (M and N) WT donor cells can populate the myocardium extensively. (O and P) In
contrast, donor cells injected with agtrl1b MO form a small number of cardiomyocytes in WT host embryos (see Table 1).
(Q–T) Perturbation of Agtrl1b signaling disrupts migration during gastrulation. Labeled donor cells were transplanted to the margin of host embryos at
4 hpf. (R) Cells injected with agtrl1bMO remained at the margin area for a prolonged period of time compared to (Q) WT cells (shown at 8 hpf). (T) WT
cells transplanted into embryos injected with apln similarly displayed delayed migration when compared to (S) WT cells placed in uninjected hosts
(shown at 10 hpf).Developmental Cell 12, 403–413, March 2007 ª2007 Elsevier Inc. 409
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Role of agtrl1b in Myocardial Progenitorsblastula) wild-type cells to wild-type hosts resulted in
21.8% of host embryos with GFP+ myocardial cells
when observed at 48 hpf (Figures 4M and 4N; Table 1).
In about half the cases in which GFP was observed in
the heart, six or more myocardial cells were evident. In
contrast, cells derived from embryos injected with agtrl1b
MO formedGFP+myocardial cells in 8.4%of thewild-type
host embryos (Table 1). In addition, hearts contained only
1–3 GFP+ cells, as opposed to the greater number fre-
quently seen when wild-type donors were used (Figures
4O and 4P).Morphant donor cells contributedwell to other
lineages, including skeletal muscle, blood cells, and neu-
rons, as evidenced by observing the rhodamine lineage
tracer (Figures S3G and S3H; Movie S1). Given the incom-
plete expressivity of the agtrl1b MO phenotype at the
lower MO doses used in these experiments (to ensure
health of the donor cells), these experiments indicate
that placing agtrl1bmorphant cells in a wild-type environ-
ment did not appreciably rescue their ability to form
myocardium, suggesting that Agtrl1b signaling is required
autonomously in myocardial progenitors.
To examine the effects of inactivating or hyperactivating
Agtrl1b signaling on cellular behavior, rhodamine-labeled
donor cells were tracked over time. Cells injected with
agtrl1bMO and transplanted into wild-type embryos con-
sistently migratedmore slowly from the margin toward the
axis of the embryo (Figures 4Q and 4R). In addition, wild-
type cells transplanted into embryos injected with apln
RNA similarly demonstrated reduced migratory behavior
(Figures 4S and 4T). It should be noted that these effects
were moderate, and that in both cases donor cells did
reach the embryonic axis, albeit in a delayed fashion.
Table 1. Transplantation Experiments Reveal a
Cell-Autonomous Requirement for Agtrl1b in
Cardiomyocyte Formation
Experiment
Donor;
Host
GFP+ Hearts/
Total
% Age GFP+
Hearts
1 WT; WT 5/20 25%
1 MO; WT 0/23 0%
2 WT; WT 12/44 27%
2 MO; WT 6/102 5.9%
3 WT; WT 7/46 15%
3 MO; WT 16/138 11.6%
Total WT; WT 24/110 21.8%
Total MO; WT 22/263 8.4%
Cells from WT or agtrl1b morphant (MO) embryos bearing
a cmlc2:EGFP transgene were transplanted into WT hosts at
3–4 hpf. At 48 hpf, the percentage of host embryos containing
GFP-positive cardiomyocytes was determined by fluores-
cence microscopy. In the third experiment, a higher percent-
age of host hearts contained MO-injected donor cells;
however, 50% of donor embryos left to develop after trans-
plantation contained beating tissue (data not shown). The ele-
vated contribution of MO donor cells observed was therefore
likely due to the incomplete penetrance of the MO phenotype.410 Developmental Cell 12, 403–413, March 2007 ª2007 ElseDISCUSSION
We present evidence for a, to our knowledge, novel func-
tion for Agtrl1b in the early development of myocardial
progenitors. Agtrl1 has been attributed to a number of
functions in adult physiology, including the regulation of
blood pressure, heart contractility, and heart failure
(Chen et al., 2003; Ishida et al., 2004; Ashley et al., 2005;
Masri et al., 2005). Targeted mutagenesis of Agtrl1 in
mouse has not been reported to affect early heart devel-
opment (Ishida et al., 2004). However, a lower than ex-
pected frequency of postnatal homozygous mutant pups
(19% versus 25%) was recovered. More recent work has
found that mouse Agtrl1 mutants do indeed have severe
cardiovascular defects, with the penetrance of the pheno-
type being influenced by genetic background (T. Querter-
mous, personal communication), indicating that Agtrl1
may regulate early cardiac development in mouse as
well. It is interesting to note that our work describes an
embryonic role for a signaling pathway that also regulates
adult cardiac function. The question of whether these
functions are ultimately achieved by differing or similar
signaling mechanisms will be interesting to pursue, as
will the effects, if any, of the grinch mutation on adult
zebrafish heart function.
An angiogenic role for Agtrl1, based on the use of MOs
inXenopus embryos, has also recently been reported (Cox
et al., 2006; Inui et al., 2006). While agtrl1b is expressed in
the developing vasculature, primary angiogenesis and
branching of the intersomitic vessels appear unaffected
in grnmutants (Figure S1). However, as the absence of cir-
culation impairs later aspects of angiogenesis (Lawson
and Weinstein, 2002), the role of agtrl1b in this process
could not be directly evaluated. It is interesting to note
that the two Xenopus publications reported differing re-
sults with respect to the phenotype observed after deple-
tion of Agtrl1. In one study (Cox et al., 2006), angiogenesis,
including intersomitic vessel branching, was perturbed. In
the second study (Inui et al., 2006), much more severe
effects on cardiovascular development were observed,
including a decreased formation of endothelial cells and
severe cardiac abnormalities. The authors ascribed the
cardiac phenotype as being secondary to the absence
of signals from endothelial/endocardial cells. However,
based on the results of our experiments (see below), we
believe that, at least in zebrafish embryos, Agtrl1b is re-
quired directly in myocardial progenitors. It is important
to note that the myocardial phenotype observed in grinch
mutants is caused by gene mutation, not by the use of
MOs, and therefore is likely a more robust indicator of
agtrl1b function. A further examination of agtrl1a/b double
mutants will be required to fully assess the role of Agtrl1
signaling in zebrafish angiogenesis.
Tellingly, both the loss and ectopic activation of Agtrl1b
signaling result in a specific reduction of myocardial pro-
genitors at the earliest stages that can be assayed by
gene expression, a novel phenotype in vertebrates. These
data suggest that Agtrl1b signaling is not required for the
induction of cardiomyogenesis. Further, coinjection ofvier Inc.
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Role of agtrl1b in Myocardial Progenitorsa p53 MO, which inhibits apoptosis in zebrafish embryos
(Langheinrich et al., 2002), did not alleviate the agtrl1b
MO phenotype (data not shown). Agtrl1b signaling there-
fore does not appear to be required for the survival of myo-
cardial progenitors. Instead, we findmore likely a model in
which Agtrl1b signaling regulates themigration ofmyocar-
dial progenitors to the correct position in the ALPM
(Figure S4). With defective migration, these myocardial
progenitors would not receive the inductive signals re-
quired to promote their differentiation. In contrast, ectopic
expression of an Agtrl1 ligand would disrupt an endoge-
nous chemotactic gradient, similarly resulting in a failure
to migrate. Transplantation data support this model, as
both agtrl1b morphant cells in a wild-type environment
and wild-type cells in a ubiquitous apln milieu appear to
migrate toward the midline more slowly. The defects ob-
served in ALPM morphology upon ectopic apln expres-
sion may reflect the failure of the migrating cells to form
a cohesive epithelial sheet. The partially penetrant nature
of the grn phenotype may therefore indicate in part the
sensitivity of myocardial progenitors, one of the first
groups of cells to ingress during gastrulation, to subtle
alterations in their migration.
Importantly, Agtrl1 signaling has previously been shown
to have promigratory activity in vitro (Hosoya et al., 2000;
Hashimoto et al., 2005). The demonstration by use of
hsp70:apln transgenic embryos that this sensitivity to
ubiquitous Agtrl1b ligand is confined to a period prior to
about 5 hpf also supports this model, as gastrulation
(and the resulting ingression of myocardial progenitors)
occurs precisely over this period of time. In transplantation
assays, agtrl1b appears to be required autonomously in
myocardial progenitors. We therefore propose that signal-
ing via Agtrl1b promotes migration of these cells, either by
directly responding to a chemotactic gradient, or by acting
permissively to bolster their migratory capacity. Themesp
family of bHLH factors also regulatesmigration of myocar-
dial progenitors during mouse and ascidian gastrulation
(Davidson et al., 2005; Saga et al., 1999; Kitajima et al.,
2000; Satou et al., 2004). However, no effects on mesp
expression were observed in grinch mutants (data not
shown).
Midline expression of the Agtrl1b ligand Apln suggests
that it may provide a signal for migration of the myocardial
progenitors. However, injection of three independent apln
MOs (designed against the 50UTR and the splice donor
site in intron 1) caused severe defects in body axis elon-
gation and morphogenesis (Figure S3D), but did not reca-
pitulate the grn myocardial phenotype, as significant
myocardium was formed in the morphants (Figure S3E).
The MOs appear to be functional, as coinjection of the
50UTR-targeted MOwas sufficient to reverse the inhibition
of cardiomyogenesis caused by apln RNA levels far ex-
ceeding those normally found in vivo (Figure S3F). While
exogenous apln can therefore recapitulate the grn pheno-
type, and Apln can act as a ligand to stimulate Agtrl1b ac-
tivity, an apln mutant will be required to definitively test
whether Apln is the in vivo signal for Agtrl1b during myo-
cardial progenitor development. While not the focus ofDevelothis study, the midline expression of apln, coupled with
the convergence extension-type defects observed in
apln morphants and embryos subjected to excess apln,
suggests that this gene may play an important role in early
embryonic morphogenesis.
The incomplete expressivity of the grn myocardial phe-
notype, despite the fact that the grns608 mutant allele ap-
pears to encode a biochemically inactive GPCR, suggests
that Agtrl1b acts redundantly or in parallel with other sig-
naling pathway(s). Coinjection of agtrl1a MO increased
the penetrance of the grn phenotype to a certain degree,
but it still did not result in a fully penetrant cardiac pheno-
type. The requirement for multiple pathways may explain
why while agtrl1b is broadly expressed in the mesendo-
derm, its activity (even upon stimulation with exogenous
Apln) appears to be specific to myocardial progenitors.
This proposed role for Agtrl1b is consistent with the re-
quirement for GPCR signaling in the migration of several
cell types, including immune system components
(Campbell et al., 2003), neurons (Knaut et al., 2005), and
primordial germ cell progenitors (Doitsidou et al., 2002;
Knaut et al., 2003; Kunwar et al., 2003; Molyneaux et al.,
2003). Therefore, the numerous GPCRs encoded in meta-
zoan genomes may regulate the migration of different cell
populations.
EXPERIMENTAL PROCEDURES
Zebrafish Strains, Microinjections, and In Situ Hybridization
grnmutants were derived from a diploid genetic screen, as previously
described (Beis et al., 2005). RNA in situ hybridization (ISH) was carried
out as previously described (Yelon et al., 1999), by using standard
probes. DNA fragments for agtrl1b, apln, and mespa in situ probes
were amplified by RT-PCR (sequences available upon request). For
RNA overexpression, cDNAs encoding apln and the mutant and
wild-type versions of agtrl1b were amplified by RT-PCR and subcl-
oned into pCS2+. Tg(flk1:EGFP)s843 and Tg(cmlc2:EGFP) fish have
been previously described (Huang et al., 2003; Jin et al., 2005). A
PCR fragment of zebrafish apelin was subcloned into a vector with
the 1.5 kb zebrafish hsp70 promoter (Halloran et al., 2000) flanked
by ISceI meganuclease restriction sites. Embryos injected with this
hsp70:apln construct and ISceI were raised to adulthood, and then
screened for germline transmission by mating with wild-type adults
and PCR genotyping of the resulting embryos. A carrier, denoted
Tg(hsp70:apln)hsc1, that transmits the transgene at a frequency of
10% was used for all experiments. Heat shocks were carried out for
30 min at 37C. Induction of expression at all time points studied
was confirmed by apln ISH.
Sequences
Sequences for zebrafish agtrl1a (NM_001075105), agtrl1b
(NM_001030197), and apln (EB962402) are available in the National
Center for Biotechnology Information.
Positional Cloning of grn
Diploid mutant embryos were obtained from grns608 carriers out-
crossed to a WIK background. The region occupied by grnwas repeat
rich, and as such both the radiation hybrid panels and genome assem-
bly were uninformative. Fortuitously, tight linkage (0 recombinants out
of 1324 diploid embryos) was found for the SSLP marker Z9473. PCR-
based screening of a BAC pool library revealed that Z9473 is located
on the 56 kb BAC zC102K8. After sequencing of the BAC zC102K8,
RFLP markers were designed by comparison of sequences from
500 bp PCR products from homozygous mutant and wild-typepmental Cell 12, 403–413, March 2007 ª2007 Elsevier Inc. 411
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markers 880/1 and 782/3. As agtrl1b is a single-exon gene, sequenc-
ing in grn mutants was carried out on PCR products from both geno-
mic and cDNA. The grns608 allele of agtrl1b eliminated a Sau96I restric-
tion site, allowing for RFLP-based genotyping, which showed that it is
very tightly linked to the grn locus (0 recombinants in 1324 diploid
embryos). Unfortunately, zC102K8 did not encompass the entire grn
critical region, and further attempts to extend the genomic contig be-
yond the end of zC102K8 have, to date, proven unsuccessful.
Morpholinos
Morpholinos targeting the 50UTR of agtrl1b (50-CAGAGAAGTTG
TTTGTCATGTGTCT-30), the 50UTR of apln (50-GATCTTCACATTCAT
TTCTGCTCTC-30), the first intron splice donor of apln (50-CACGCT
CCCGACTTACCAGCACTGG-30 and 50-AACAGCCGTCACGCTCCC
GACTTAC-30), the 50UTR of agtrl1a (50-TGTATTCCGACGTTGGCTC
CATTTG-30 ), the 50UTR of p53 (50-GCGCCATTGCTTTGCAAGAA
TTG-30), and a mismatch control agtrl1b MO (50-CACAGAACTTGT
TTCTCATCTCTCT-30; underlined nucleotides denote changes made
for the mismatch MO) were purchased from Gene Tools and Open
Biosystems. A total of 2.0–8.0 ng of each MO was injected into
1-cell-stage embryos.
Analysis of Agtrl1b Signaling
The Flp-In system (Invitrogen) was used to generate isogenic, stable
CHO cell lines expressing wild-type or mutant versions of agtrl1b.
For adenylylcyclase assays, cells were treatedwithmedium containing
20 mM forskolin and 0.5 mM 3-isobutyl-1-methylxanthine in the pres-
ence or absence of 1 mM of the indicated Apln fragment. After incuba-
tion for 15 min, cells were lysed, and cAMP levels were determined by
radioimmunoassay (Immunotech, Beckman Coulter). ERK and p70S6
kinase activities were determined in serum-starved cells stimulated at
37C for 5 min in the absence or presence of 1 mM Apln fragment.
Western blotting was carried out by using anti-phospho-ERK and
anti-phospho-Thr389 p70S6 kinase primary antibodies, followed by
incubation with HRP-conjugated secondary antibody and chemilumi-
nescent detection of HRP activity (Amersham Biosciences).
Transplantation
Transplantation experiments were carried out as previously described
(Parker and Stainier, 1999). Donor cmlc2:EGFP embryos were injected
with 2 ng agtrl1bATGMOormismatch controlMOandwere labeled by
coinjection of 5% tetramethyl rhodamine dextran (MW 10,000, Molec-
ular Probes). A total of 10–20 cells were removed from the margin of
3–4 hpf donor embryos and were transplanted to the margin of wild-
type host embryos. In order to control for variation in contribution
to the heart at different time periods, transplantation of wild-type and
morphant embryos were staggered during the same experiment
such that results could be compared directly.
Supplemental Data
Supplemental Data include Figures S1–S4, Table S1, and Movie S1
and are available at http://www.developmentalcell.com/cgi/content/
full/12/3/403/DC1/.
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